Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Jacob

Showing results (821-830 of 911) with videos related to

Pageof 92
Sort By:
Allergy|July 11, 2023
Dupilumab sustains efficacy in patients with moderate-to-severe type 2 asthma regardless of inhaled corticosteroids doseIan D Pavord, Arnaud Bourdin, Alberto Papi, et al.
Stroke|October 30, 2025
Cholinergic Disruption Contributes to Motoric Cognitive Dysfunction in Cerebral Small Vessel DiseaseMengfei Cai, Hao Li, Milan Nemy, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|September 26, 2023
Efficacy of dupilumab in patients with uncontrolled, moderate-to-severe asthma with fungal sensitizationJonathan Corren, Nicola A Hanania, William W Busse, et al.
Respiratory Medicine|July 16, 2013
Fluticasone/formoterol dry powder versus budesonide/formoterol in adults and adolescents with uncontrolled or partly controlled asthmaA Cukier, C M A Jacob, N A Rosario Filho, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|December 29, 2023
Impact of Dupilumab on Sinonasal Symptoms and Outcomes in Severe Chronic Rhinosinusitis With Nasal PolypsClaire Hopkins, Joaquim Mullol, Asif H Khan, et al.
Respiratory Medicine|September 10, 2022
Dupilumab efficacy in subgroups of type 2 asthma with high-dose inhaled corticosteroids at baselineArnaud Bourdin, J Christian Virchow, Alberto Papi, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|September 29, 2024
Mild and symptom-free months in patients with chronic rhinosinusitis with nasal polyps treated with dupilumabClaus Bachert, Asif H Khan, Claire Hopkins, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 26, 2022
Dupilumab Efficacy in Patients With Uncontrolled or Oral Corticosteroid-Dependent Allergic and Nonallergic AsthmaGuy Brusselle, Santiago Quirce, Alberto Papi, et al.
American Journal of Respiratory and Critical Care Medicine|February 8, 2024
Biomarkers Associated with Lung Function Decline and Dupilumab Response in Patients with AsthmaIan D Pavord, Lucia De Prado Gómez, Guy Brusselle, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|September 6, 2022
Dupilumab efficacy and safety in Latin American patients with uncontrolled, moderate-to-severe asthma: phase 3 LIBERTY ASTHMA QUEST studyJorge F Maspero, Guido Cardona, Patricia Schonffeldt, et al.
Pageof 92

Showing results (821-830 of 911) with videos related to

Sort By:
Pageof 92
Allergy|July 11, 2023
Dupilumab sustains efficacy in patients with moderate-to-severe type 2 asthma regardless of inhaled corticosteroids doseIan D Pavord, Arnaud Bourdin, Alberto Papi, et al.
Stroke|October 30, 2025
Cholinergic Disruption Contributes to Motoric Cognitive Dysfunction in Cerebral Small Vessel DiseaseMengfei Cai, Hao Li, Milan Nemy, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|September 26, 2023
Efficacy of dupilumab in patients with uncontrolled, moderate-to-severe asthma with fungal sensitizationJonathan Corren, Nicola A Hanania, William W Busse, et al.
Respiratory Medicine|July 16, 2013
Fluticasone/formoterol dry powder versus budesonide/formoterol in adults and adolescents with uncontrolled or partly controlled asthmaA Cukier, C M A Jacob, N A Rosario Filho, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|December 29, 2023
Impact of Dupilumab on Sinonasal Symptoms and Outcomes in Severe Chronic Rhinosinusitis With Nasal PolypsClaire Hopkins, Joaquim Mullol, Asif H Khan, et al.
Respiratory Medicine|September 10, 2022
Dupilumab efficacy in subgroups of type 2 asthma with high-dose inhaled corticosteroids at baselineArnaud Bourdin, J Christian Virchow, Alberto Papi, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|September 29, 2024
Mild and symptom-free months in patients with chronic rhinosinusitis with nasal polyps treated with dupilumabClaus Bachert, Asif H Khan, Claire Hopkins, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 26, 2022
Dupilumab Efficacy in Patients With Uncontrolled or Oral Corticosteroid-Dependent Allergic and Nonallergic AsthmaGuy Brusselle, Santiago Quirce, Alberto Papi, et al.
American Journal of Respiratory and Critical Care Medicine|February 8, 2024
Biomarkers Associated with Lung Function Decline and Dupilumab Response in Patients with AsthmaIan D Pavord, Lucia De Prado Gómez, Guy Brusselle, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|September 6, 2022
Dupilumab efficacy and safety in Latin American patients with uncontrolled, moderate-to-severe asthma: phase 3 LIBERTY ASTHMA QUEST studyJorge F Maspero, Guido Cardona, Patricia Schonffeldt, et al.
Pageof 92